Medifast, Inc.’s (MED) share price has entered into oversold territory with a stochastic value of 9.776. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 7 cents over the past two months to $1.45 per share. Medifast, Inc. is a Zacks #1 Rank (“Strong Buy”) company.
More From Zacks.com
- Investment & Company Information